Siga Technologies (SIGA) Research & Development (2010 - 2025)
Siga Technologies (SIGA) reported Research & Development of $7.1 million for Q3 2025, up 133.22% on a YoY basis from $3.0 million in Q3 2024, and up 60.39% quarter-over-quarter from $4.4 million in Q2 2025.
Siga Technologies (SIGA) Research & Development (2010 - 2025) Analysis & Trends
Siga Technologies has reported Research & Development for 16 years, with the latest figure at $7.1 million in Q3 2025.
- For the quarter ending Q3 2025, Research & Development rose 133.22% year-over-year to $7.1 million; the trailing twelve-month figure through Sep 2025 stood at $18.3 million (up 57.61% YoY), and the FY2024 full-year result was $12.3 million, down 25.06% from the prior year.
- Research & Development for Q3 2025 stood at $7.1 million, up from $4.4 million in the prior quarter.
- The five-year high for Research & Development was $7.1 million in Q3 2025, with the low at $2.1 million in Q4 2021.
- Historically, Research & Development has averaged $4.0 million across 5 years, with a median of $3.5 million in 2025.
- Annual changes were most pronounced in 2022 — Research & Development soared 202.13% — and 2023, when it plunged 59.14%.
- Siga Technologies' Research & Development stood at $2.1 million in 2021, then jumped by 199.29% to $6.4 million in 2022, then sank by 59.14% to $2.6 million in 2023, then increased by 27.74% to $3.3 million in 2024, then soared by 110.95% to $7.1 million in 2025.
- The last three Research & Development figures came in at $7.1 million (Q3 2025), $4.4 million (Q2 2025), and $3.5 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 222.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 180.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 138.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 934,363.43 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 296.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 97.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 103.35 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 39.38 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 46.94 Mn |
| 10 | Siga Technologies | 310.79 Mn | 155.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 7.05 Mn |
| Jun 30, 2025 | 4.40 Mn |
| Mar 31, 2025 | 3.46 Mn |
| Dec 31, 2024 | 3.34 Mn |
| Sep 30, 2024 | 3.02 Mn |
| Jun 30, 2024 | 2.89 Mn |
| Mar 31, 2024 | 3.05 Mn |
| Dec 31, 2023 | 2.62 Mn |
| Sep 30, 2023 | 3.65 Mn |
| Jun 30, 2023 | 5.12 Mn |
| Mar 31, 2023 | 5.05 Mn |
| Dec 31, 2022 | 6.41 Mn |
| Sep 30, 2022 | 5.73 Mn |
| Jun 30, 2022 | 6.84 Mn |
| Mar 31, 2022 | 3.55 Mn |
| Dec 31, 2021 | 2.14 Mn |
| Sep 30, 2021 | 3.24 Mn |
| Jun 30, 2021 | 2.26 Mn |
| Mar 31, 2021 | 2.30 Mn |
| Dec 31, 2020 | 3.01 Mn |